Assessment of a Simplified Format of Written Patient Prescription Drug Information

被引:5
|
作者
Papay, Julie I. [1 ]
Fritz, Deborah [2 ]
Cantu, Tom [3 ]
Ellis, Melissa [4 ]
Debussey, Sandy [5 ]
机构
[1] GlaxoSmithKline Inc, Global Clin Safety & Pharmacovigilance, Safety Evaluat & Risk Management, Res Triangle Pk, NC 27709 USA
[2] GlaxoSmithKline Inc, Healthcare Policy & Stand, US Pharmaceut, Res Triangle Pk, NC 27709 USA
[3] GlaxoSmithKline Inc, Global Regulatory Afffairs, Labeling, Upper Merion, PA USA
[4] GlaxoSmithKline Inc, Global Regulatory Afffairs, Labeling, Res Triangle Pk, NC 27709 USA
[5] GlaxoSmithKline Inc, Publ & Private Inst Customers, US Pharmaceut, Res Triangle Pk, NC 27709 USA
来源
DRUG INFORMATION JOURNAL | 2010年 / 44卷 / 04期
关键词
Consumer medication information; CMI; Prescription drug information; MEDICATION INSTRUCTIONS;
D O I
10.1177/009286151004400403
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Patients in the United States receive multiple forms of written information about their prescription medications. This pilot study was conducted to evaluate alternative formats of patient-directed written prescription information for four medications: cefaclor suspension, simvastatin tablets, albuterol inhaler, and capecitabine tablets. Fifty-four consumers evaluated this information using a 5-point satisfaction scale, responding to 10-12 questions, and participating in group discussion. Overall, consumers valued short, simple text, a question-answer format, a table layout, large font, adequate text spacing, bold type for emphasis, and easy-to-understand, actionable information that included impact statements on activities and lifestyle. This pilot study reveals that simplified prescription information with improved readability and reduced ambiguity may enhance consumer information retrieval and reinforce appropriate use of prescription medicines.
引用
收藏
页码:375 / 391
页数:17
相关论文
共 50 条
  • [31] FDA PUSHES FOR PRESCRIPTION DRUG INFORMATION
    MARWICK, C
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1995, 273 (23): : 1815 - 1816
  • [32] Encouraging trend on prescription drug information
    Marwick, C
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1997, 277 (22): : 1746 - 1747
  • [33] Getting to Better Prescription Drug Information
    Steven Woloshin
    Lisa M. Schwartz
    Journal of General Internal Medicine, 2012, 27 : 1582 - 1584
  • [34] COMMUNICATING PRESCRIPTION DRUG INFORMATION TO THE ELDERLY
    MORRIS, L
    GERONTOLOGIST, 1985, 25 : 199 - 199
  • [35] RECEIPT OF PRESCRIPTION DRUG INFORMATION BY THE ELDERLY
    MOORE, SR
    KALU, M
    YAVAPRABBAS, S
    DRUG INTELLIGENCE & CLINICAL PHARMACY, 1983, 17 (12): : 920 - 923
  • [36] INFORMED CONSENT FOR A PRESCRIPTION DRUG - IMPACT OF DISCLOSED INFORMATION ON PATIENT UNDERSTANDING AND MEDICAL OUTCOMES
    QUAID, KA
    FADEN, RR
    VINING, EP
    FREEMAN, JM
    PATIENT EDUCATION AND COUNSELING, 1990, 15 (03) : 249 - 259
  • [37] Useful patient information on prescription drugs
    Halperin, JA
    ANNALS OF PHARMACOTHERAPY, 1998, 32 (05) : 612 - 612
  • [38] ASSESSMENT OF UNIQUENESS OF INFORMATION PROVIDED BY POSTENCOUNTER WRITTEN SCORES ON STANDARDIZED-PATIENT EXAMINATIONS
    COLLIVER, JA
    TRAVIS, TA
    ROBBS, RS
    VU, NV
    MARCY, ML
    BARROWS, HS
    EVALUATION & THE HEALTH PROFESSIONS, 1992, 15 (04) : 465 - 474
  • [39] EFFECT OF LABEL FORMAT ON INFORMATION RECALL IN PATIENTS RECEIVING PRESCRIPTION MEDICATIONS
    MCKNIGHT, PT
    BRIER, KL
    SCHNEIDER, PJ
    CONTEMPORARY PHARMACY PRACTICE, 1981, 4 (03) : 150 - 154
  • [40] The optimal content and format of prescription drug labels: A systematic review of the literature
    Shrank, William H.
    Avorn, Jerry
    Rolon, Cony
    Shekelle, Paul
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2006, 15 : S188 - S188